Showing results (291-300 of 346) with videos related to

Sort By:
Pageof 35
Oncology Reports|April 23, 2020
RET receptor expression and interaction with TRK receptors in neuroblastomasLaura H Tetri, Venkatadri Kolla, Rebecca L Golden, et al.
The New England Journal of Medicine|October 16, 1999
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer GroupK K Matthay, J G Villablanca, R C Seeger, et al.
British Journal of Cancer|April 30, 2009
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology CommitteeP F Ambros, I M Ambros, G M Brodeur, et al.
Medical and Pediatric Oncology|July 24, 2001
Biological aspects of neuroblastomas identified by mass screening in QuebecG M Brodeur, A T Look, H Shimada, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2011
Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium studyJane E Minturn, Audrey E Evans, Judith G Villablanca, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 24, 2022
Collaboration to Promote Research and Improve Clinical Care in the Evolving Field of Childhood Cancer PredispositionSuzanne P MacFarland, Luke Maese, Surya P Rednam, et al.
Journal of Pediatric Hematology/Oncology|June 11, 1999
Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survivalS G DuBois, Y Kalika, J N Lukens, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Screening for neuroblastoma is ineffective in reducing the incidence of unfavourable advanced stage disease in older childrenW G Woods, M Tuchman, L L Robison, et al.
Physical Review Letters|July 22, 2015
First Direct Determination of the Superallowed β-Decay QEC Value for (14)OA A Valverde, G Bollen, M Brodeur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force reportSusan L Cohn, Andrew D J Pearson, Wendy B London, et al.
Pageof 35